入住重症监护室的80岁及以上老年患者中限制或撤除生命支持治疗的决策
该前瞻性研究纳入21个欧洲国家309个ICU中年龄≥80岁的重症患者,随访30天死亡率,记录并分析限制或撤除生命支持治疗(LST)的决策。5021例患者中1356例(27.2%)发生LST限制:15%为不启动(withholding)决策,12.2%为撤除(withdrawal)决策(包括此前已有限制决策者)。撤除LST组ICU死亡率和30天死亡率分别为82.2%和93.1%,不启动LST组分别为29.1%和53.1%。与LST限制独立相关的患者因素包括急性ICU入院(OR 5.77)、临床衰弱量表评分(OR 2.08)、年龄每增加5岁(OR 1.22)和SOFA评分每分(OR 1.07)。东欧和南欧国家LST限制频率低于北欧,高GDP国家和宗教国家频率分别较高和较低。
要点
- ≥80岁ICU患者中27.2%(1356/5021)发生LST限制:15%不启动,12.2%撤除(含此前已限制者)。
- 撤除LST组ICU死亡率82.2%、30天死亡率93.1%;不启动LST组分别为29.1%和53.1%。
- 急性ICU入院(OR 5.77,95%CI 4.32-7.7)、CFS评分(OR 2.08,95%CI 1.78-2.42)、年龄每增5岁(OR 1.22,95%CI 1.12-1.34)、SOFA每分(OR 1.07,95%CI 1.05-1.09)与LST限制独立相关。
- 接受LST限制的患者更年长、更衰弱、病情更重、择期入院更少;撤除LST组男性更多、ICU住院时间更长。
- 东欧和南欧LST限制频率低于北欧;高GDP国家频率较高,宗教国家频率较低。
适用人群与场景
- 21个欧洲国家309个ICU中年龄≥80岁的重症监护患者,前瞻性纳入并随访30天死亡率。
- 接受LST限制的患者更年长、更衰弱、病情更重、择期入院更少;撤除LST组男性更多、ICU住院时间更长。
研究设计与关键结果
- 研究类型:前瞻性研究,纳入21个欧洲国家309个ICU中年龄≥80岁患者5021例,随访30天死亡率。
- LST限制见于1356/5021(27.2%):15%为不启动决策,12.2%为撤除决策(包括此前已有限制决策者)。
- 不启动LST组ICU死亡率29.1%、30天死亡率53.1%;撤除LST组ICU死亡率82.2%、30天死亡率93.1%。
- 与LST限制独立相关的患者因素:急性ICU入院OR 5.77(95%CI 4.32-7.7)、CFS评分OR 2.08(95%CI 1.78-2.42)、年龄每增5岁OR 1.22(95%CI 1.12-1.34)、SOFA评分每分OR 1.07(95%CI 1.05-1.09)。
- 东欧和南欧国家LST限制频率低于北欧;高GDP国家频率较高,宗教国家频率较低。
证据类型、等级与局限
- 证据类型:前瞻性研究(ClinicalTrials.gov ID NTC03134807),原文未报告证据等级。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在≥80岁ICU患者中,急性入院、CFS评分、年龄和入ICU SOFA评分是与LST限制决策独立相关的患者因素,可据此识别可能面临LST限制决策的人群。
- LST限制频率存在地区差异:东欧和南欧低于北欧,高GDP国家较高、宗教国家较低,提示决策受国家层面因素影响。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: To document and analyse the decision to withhold or withdraw life-sustaining treatment (LST) in a population of very old patients admitted to the ICU.
METHODS: This prospective study included intensive care patients aged ≥ 80 years in 309 ICUs from 21 European countries with 30-day mortality follow-up.
RESULTS: LST limitation was identified in 1356/5021 (27.2%) of patients: 15% had a withholding decision and 12.2% a withdrawal decision (including those with a previous withholding decision). Patients with LST limitation were older, more frail, more severely ill and less frequently electively admitted. Patients with withdrawal of LST were more frequently male and had a longer ICU length of stay. The ICU and 30-day mortality were, respectively, 29.1 and 53.1% in the withholding group and 82.2% and 93.1% in the withdrawal group. LST was less frequently limited in eastern and southern European countries than in northern Europe. The patient-independent factors associated with LST limitation were: acute ICU admission (OR 5.77, 95% CI 4.32-7.7), Clinical Frailty Scale (CFS) score (OR 2.08, 95% CI 1.78-2.42), increased age (each 5 years of increase in age had a OR of 1.22 (95% CI 1.12-1.34) and SOFA score [OR of 1.07 (95% CI 1.05-1.09 per point)]. The frequency of LST limitation was higher in countries with high GDP and was lower in religious countries.
CONCLUSIONS: The most important patient variables associated with the instigation of LST limitation were acute admission, frailty, age, admission SOFA score and country.
TRIAL REGISTRATION: ClinicalTrials.gov (ID: NTC03134807).
参考来源
- Guidet B, Flaatten H, Boumendil A, et al. Withholding or withdrawing of life-sustaining therapy in older adults (≥ 80 years) admitted to the intensive care unit. Intensive Care Med. 2018. PMID: 29774388. doi:10.1007/s00134-018-5196-7
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。